Hepatitis B core-related antigen levels predict recurrence-free survival in patients with HBV-associated early-stage hepatocellular carcinoma: results from a Dutch long-term follow-up study
Prognosis of hepatitis B (HBV)-associated hepatocellular carcinoma (HCC) is poor due to high rates of HCC recurrence and progression of underlying liver disease. We studied whether serum hepatitis B core-related antigen (HBcrAg) levels could predict HCC recurrence and outcome in HBV associated. Higher HBcrAg levels at HCC diagnosis were independently associated with reduced overall and recurrence-free survival in patients with early, but not advanced, stage HCC.
Verfasser: |
Beudeker, Boris
Groothuismink, Anthonie
de Man, Rob
Witjes, Carlijn
Baltissen - van der Eijk, Annemiek
Boonstra, Andre
Sonneveld, Milan |
Dokumenttyp: |
Artikel |
Erscheinungsdatum: |
2021 |
Reihe/Periodikum: |
Beudeker , B , Groothuismink , A , de Man , R , Witjes , C , Baltissen - van der Eijk , A , Boonstra , A & Sonneveld , M 2021 , ' Hepatitis B core-related antigen levels predict recurrence-free survival in patients with HBV-associated early-stage hepatocellular carcinoma: results from a Dutch long-term follow-up study ' , Journal of Viral Hepatitis , vol. 28 , no. 1 , pp. 205-208 . https://doi.org/10.1111/jvh.13394 |
Schlagwörter: |
/dk/atira/pure/keywords/researchprograms/AFL001000/EMCOR01
/ name=EMC OR-01
/ /dk/atira/pure/sustainabledevelopmentgoals/good_health_and_well_being
/ name=SDG 3 - Good Health and Well-being |
Sprache: |
Englisch |
Permalink: |
https://search.fid-benelux.de/Record/base-27072253 |
Datenquelle: |
BASE;
Originalkatalog |
Powered By: |
BASE |
Link(s) :
|
https://pure.eur.nl/en/publications/786cd495-dedf-489d-b97f-013b730be983 |